Skip to main content

Judit Grau Exposito

Institutions of which they are part

Research technician
Infectious Diseases
Vall Hebron Institut de Recerca

Judit Grau Exposito

Institutions of which they are part

Research technician
Infectious Diseases
Vall Hebron Institut de Recerca

Projects

Impact of early treatment during acute HIV infection on the metabolism of reservoir and immune effector cells: Identification of new targets to reduce persistent HIV

IP: Jordi Navarro Mercadé
Collaborators: Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Vicenç Falcó Ferrer, Bibiana Planas Ribas, Vicente Descalzo Jorro, Paula Suanzes Diez, Judit Grau Exposito
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI20/00823
Duration: 01/01/2021 - 30/06/2025

The efficacy of Lauric Acid, a dietary fatty acid, at impacting the HIV latent reservoir. The FATHIV clinical study

IP: Joaquin Burgos Cibrian
Collaborators: Adria Curran Fàbregas, Bibiana Planas Ribas, Paula Suanzes Diez, Judit Grau Exposito
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI20/01080
Duration: 01/01/2021 - 30/06/2025

Desenvolupament de noves nanopartícules funcionals dirigides al nòdul limfàtic per a l'eliminació del reservori latent de VIH

IP: María José Buzón Gómez
Collaborators: Ibane Abasolo Olaortua, Félix Pumarola Segura, Juan Lorente Guerrero, Laura García Latorre, Jordi Temprana Salvador, Joaquin Seras Franzoso, Marc Pellicer Sarasa, David Perea Pérez, Simon Schwartz Navarro, Jordi Navarro Mercadé, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Judit Grau Exposito, Meritxell Genesca Ferrer, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael
Funding agency: Fundació La Marató de TV3
Funding: 199998.75
Reference: 20180510
Duration: 10/05/2019 - 31/12/2022

Characterization of in vivo resting CD4 T cells expressing HIV RNA in ART-treated individuals Grant Number: 5R21AI118411-02

IP: María José Buzón Gómez
Collaborators: Judit Grau Exposito
Funding agency: National Institutes of Health (NIH)
Funding: 271011.41
Reference: MICROTAR_NIH2015
Duration: 01/08/2015 - 31/07/2018

Related news

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

Related professionals

Lluc Molins Ciutat

Lluc Molins Ciutat

Administrative
Clinical Research Support Unit (USIC)
Clinical Core Facilities
Core Facilities Area
Read more
Idoia Bolinaga Ayala

Idoia Bolinaga Ayala

Predoctoral researcher
Protein kinases in cancer research
Read more
Laia Rubio Ortega

Laia Rubio Ortega

Research technician
Gene Therapy at Nervous System
Read more
Montse Rodriguez Gomez

Montse Rodriguez Gomez

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.